1-4 of 4
Allen Poma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Obexelimab in Patients with Warm Autoimmune Hemolytic Anemia: Preliminary Results from an Open Label Phase 2 Study

Bruno Fattizzo, Gillian Evans, Audrey Wells, Allen Poma, Shauna Quinn, Dale Zhang, Mason Yamashita, Tanya Z. Fischer
Journal: Blood
Blood (2024) 144 (Supplement 1): 5212.
https://doi.org/10.1182/blood-2024-206100
Published: 2024
Journal Articles

101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)

Steven Pipe, MD, Kimo Stine, MD, Anita Rajasekhar, MD, Tamara Everington, MD, Allen Poma, MD, Eric Crombez, MD, Charles RM Hay, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3331.
https://doi.org/10.1182/blood.V130.Suppl_1.3331.3331
Published: 2017
Journal Articles

The Evaluation of Long-Term Ferumoxytol Use as An Iron Replacement Therapy In Patients with Iron Deficiency Anemia

Allen Poma, MD, MBA, Karen Diana, MS, Justin McLaughlin, MA, Annamaria Kausz, MD, MS
Journal: Blood
Blood (2010) 116 (21): 5156.
https://doi.org/10.1182/blood.V116.21.5156.5156
Published: 2010
Journal Articles

A Head-to-Head Comparison of the Safety and Efficacy of Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia

Allen Poma, MD, MBA, Karen Diana, MS, Justin McLaughlin, MA, Annamaria Kausz, MD, MS
Journal: Blood
Blood (2010) 116 (21): 5157.
https://doi.org/10.1182/blood.V116.21.5157.5157
Published: 2010